Meifang Zheng

Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study

Yuqin Song, Luis Malpica, Qingqing Cai et al. · The Lancet Oncology · 2023 · 55 citations

Medicine, Oncology, Pharmacology +13

Interleukin-6 participates in human pancreatic stellate cell activation and collagen I production via TGF-β1/Smad pathway

Meifang Zheng, Hongyan Li, Li Sun et al. · Cytokine · 2021 · 38 citations · Full text

Veterinary Medicine, Cell Biology, Pathobiology +15

The preablation monocyte/ high density lipoprotein ratio predicts the late recurrence of paroxysmal atrial fibrillation after radiofrequency ablation

She-an Chen, Man-man Zhang, Meifang Zheng et al. · BMC Cardiovascular Disorders · 2020 · 27 citations · Full text

Medicine, Cardiology, Clinical Cardiology +12

Mean platelet volume: a new predictor of ischaemic stroke risk in patients with nonvalvular atrial fibrillation

Meifang Zheng, She-an Chen, Ye Zhu et al. · BMC Cardiovascular Disorders · 2020 · 19 citations · Full text

Medicine, Cardiology, Hematology +15

Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial

Yuqin Song, Hui Zhou, Huilai Zhang et al. · Advances in Therapy · 2021 · 19 citations

Medicine, Hematology, Oncology +5